In addition to regulating HIF1α expression through inhibition of FIH1, miR-24 further aids cancer cells by targeting pro-apoptotic BCL2-like 11 (BCL2L11, Bim) to promote resistance towards chemotherapy-driven apoptosis in breast CSCs (41). Here, BCL2L11 is linked to cancer.